A clinical trial protocol to evaluate the accuracy of brain electrical impedance tomography in screening for supratentorial tumors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039315

Enrollment

Unknown

Registered

2020-10-23

Start date

2020-05-29

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

Gold Standard:MRI/CT

Index test:Brain&#32

electrical&#32

impedance&#32

tomography.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Those who are 18 years old = 3cm; 4. Patients who have signed informed consent. 5. Those who have shaved their hair. 6. The object of smooth communication.

Exclusion criteria

Exclusion criteria: 1. Patients with severe combined injuries or hemorrhagic shock; 2. Patients with epilepsy and poisoning symptoms; 3. Critically ill patients; 4. Patients with brain injury or acute inflammation; 5. Women in lactation and pregnancy; 6. Subjects who have no ability of informed consent or can not sign on their own; 7. Patients who are considered unsuitable to participate in this clinical trial.

Design outcomes

Primary

Measure	Time frame
Cerebral electrical impedance;accuracy;	—

Countries

China

Contacts

Public ContactZhang Jianmin

Department of Neurosurgery, The Second Affiliated Hospital of Medical College of Zhejiang University

zjm135@zju.edu.cn+86 13805722695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026